
|Articles|July 21, 2008
FDA retracts hold on alvimopan
However, partner in drug development deal may be backing out.
Advertisement
The
Alvimopan (Entereg) received FDA approval in May for the treatment of post-operative ileus. The following month, FDA issued a hold on further studies of the drug pending submission and requested data analysis.
To see more Daily News articles,
To go to the Drug Topics homepage,
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
2
Study Identifies Patients at Risk for Severe COVID-19 Post-Vaccination
3
Investigational Oral AD109 Reduces Sleep Apnea Severity by 44%
4
Zepbound Lowers Health Care Costs in Older Adults With Obesity
5






































